Kolmar BioTech, Inc. (KOSDAQ:215380)
South Korea · Delayed Price · Currency is KRW 2,360.00
0.00 (0.00%)
At close: Aug 11, 2026
Kolmar BioTech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 39,718 | 29,637 | 28,610 | 27,081 | 38,678 | 80,970 | |
Market Cap Growth | 43.64% | 3.59% | 5.65% | -29.98% | -52.23% | -29.00% |
Enterprise Value | 55,428 | 78,865 | 75,576 | 84,550 | 87,971 | 116,281 |
Last Close Price | 2360.00 | 1761.00 | 1700.00 | 2090.00 | 2985.00 | 6290.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 126.99 | - | - | - |
PS Ratio | 0.99 | 0.79 | 0.66 | 0.70 | 0.82 | 2.59 |
PB Ratio | 1.71 | 1.27 | 0.97 | 1.23 | 1.30 | 2.54 |
P/TBV Ratio | 1.78 | 1.32 | 1.00 | 1.29 | 1.35 | 2.66 |
P/OCF Ratio | - | - | - | - | 15.46 | 46.86 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.38 | 2.10 | 1.75 | 2.19 | 1.88 | 3.72 |
EV/EBITDA Ratio | 29.58 | 674.42 | 12.63 | 283.56 | 50.98 | - |
EV/EBIT Ratio | - | - | 42.35 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.28 | 2.16 | 1.74 | 2.38 | 1.37 | 1.22 |
Debt / EBITDA Ratio | 28.14 | 432.05 | 8.52 | 175.46 | 23.58 | - |
Net Debt / Equity Ratio | 0.68 | 1.99 | 1.58 | 2.12 | 1.20 | 1.01 |
Net Debt / EBITDA Ratio | 8.37 | 396.82 | 7.77 | 156.18 | 20.68 | -27.71 |
Net Debt / FCF Ratio | -4.12 | -52.47 | -32.80 | -11.46 | -4.00 | -0.92 |
Asset Turnover | 0.38 | 0.41 | 0.45 | 0.40 | 0.48 | 0.37 |
Inventory Turnover | 3.97 | 4.26 | 6.58 | 8.19 | 10.10 | 6.25 |
Quick Ratio | 0.65 | 0.26 | 0.33 | 0.28 | 0.17 | 0.35 |
Current Ratio | 0.81 | 0.57 | 0.64 | 0.43 | 0.31 | 0.67 |
Return on Equity (ROE) | -14.57% | -21.03% | 0.88% | -19.55% | -6.10% | -5.91% |
Return on Assets (ROA) | -1.06% | -2.52% | 1.16% | -2.60% | -1.62% | -2.84% |
Return on Invested Capital (ROIC) | -3.35% | -5.02% | 2.47% | -6.01% | -3.89% | -7.23% |
Return on Capital Employed (ROCE) | -3.20% | -6.40% | 2.80% | -7.60% | -5.10% | -6.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -9.26% | -18.71% | 0.79% | -18.66% | -4.86% | -2.38% |
FCF Yield | -9.61% | -2.98% | -4.96% | -15.01% | -23.06% | -43.17% |
Buyback Yield / Dilution | -4.43% | -23.55% | -17.40% | 0.65% | -7.66% | -3.36% |